DailyMail
-
UK investors pour cash into US equities, data shows
The 'worst-selling' sector in March was UK All Companies, which experienced outflows of £887m, according to the Investment Association.
-
Standard Chartered beats profit estimates as higher interest rates boost income
Bank saw a 6% increase in reported pre-tax profit of $1.9billion in the first quarter, compared with $1.81billion the previous year and beating...
-
Royal bank Coutts risks backlash as it plans to move £2billion of clients' cash out of the London stock market and into foreign investments
Elite private bank Coutts, which is almost 30 per cent owned by taxpayers, said its 'home bias' towards UK shares was an 'anachronism' requiring...
-
I'm 'very well paid', says Glaxo boss Emma Walmsley
Dame Emma Walmsley (pictured), who earned £12.7m in 2023, said she felt 'really good' about ithe drugs giant's ability to retain talent.
-
BUSINESS LIVE: UK outlook worsened; Shell beats forecasts; Standard Chartered buoyed by higher interest rates
Among the companies with reports and trading updates today are Shell, Standard Chartered, Melrose Industries and Apple.
-
Hiscox reports rise in premiums - but warns of 'moderate' loss from fallout of Baltimore Bridge crash
In the first three months of the year, total insurance contract written premiums (ICWP) increased 8.3% to $1.5billion.
-
Smith & Nephew rocked as 43% of investors rebel over fat cat pay
In what amounted to a bloody nose for the FTSE 100 firm, 43% of investors voted against raising Deepak Nath's maximum earnings to £9.4m.
-
The £80bn takeover feeding frenzy: Bids for UK firms soar
Overseas buyers accounted for £63bn, or more than 80% of takeover offers in the UK from January to April, according the London Stock Exchange.
-
US drugs giant Pfizer posts a drop in sales in a post-Covid vaccine slump
Pfizer reported revenues of £11.9bn for the first three months of 2024, down a fifth year-on-year, as it tries to regain its footing post-Covid.
-
Pandol and Advil maker Haleon hurt by milder flu season
Demand for its cough and cold medicines took a hit, and it noted particularly poor performances for its ibuprofen brand Advil in Canada.
-
US Federal Reserve forced to calm fears over rate hikes
Fed chief Jerome Powell (pictured) said a hike was 'unlikely' but made clear that if inflation continues to move 'sideways' rates will not be...
-
Customers are shying away from big ticket purchases, says Wickes
The home improvement retailer, which Travis Perkins previously owned, said its like-for-like sales fell by 4.2% in the 16 weeks ending 20 April.